Pharma company ranking based on R&D for developing countries 2018

Pharmaceutical company ranking based on R&D for developing countries in 2018*

Pharma company ranking based on R&D for developing countries 2018 This statistic depicts a pharmaceutical company ranking based on R&D for developing countries in 2018, according to the Access to Medicine Index 2018. In that year, the leading company concerning research and development for these markets was GlaxoSmithKline with an indicator score of four points. The Access to Medicine Index is an independent initiative that ranks the world’s 20 largest companies according to their efforts to make their products more available, affordable and accessible in developing countries, highlighting policy and practice that either facilitate or hinder access to medicine.
Show more

Pharmaceutical company ranking based on R&D for developing countries in 2018*

Loading statistic...
Expand statistic
Indicator score from 1 (lowest) to 5 (highest)
GlaxoSmithKline plc4
Merck KGaA3.69
Novartis AG3.55
Johnson & Johnson3.19
Sanofi2.83
Eisai Co. Ltd.2.8
Takeda Pharmaceutical Co.2.8
Daiichi Sankyo Co. Ltd.2.71
Bayer AG2.14
Novo Nordisk A/S2.09
AstraZeneca plc2.05
Astellas Pharma Inc.2.01
AbbVie Inc.1.98
Pfizer Inc.1.9
Roche Holding Ltd1.84
Merck & Co. Inc.1.78
Boehringer-Ingelheim GmbH1.73
Bristol-Myers Squibb Co.1.56
Gilead Sciences Inc.1.43
Eli Lilly & Co.0.88
Indicator score from 1 (lowest) to 5 (highest)
GlaxoSmithKline plc4
Merck KGaA3.69
Novartis AG3.55
Johnson & Johnson3.19
Sanofi2.83
Eisai Co. Ltd.2.8
Takeda Pharmaceutical Co.2.8
Daiichi Sankyo Co. Ltd.2.71
Bayer AG2.14
Novo Nordisk A/S2.09
AstraZeneca plc2.05
Astellas Pharma Inc.2.01
AbbVie Inc.1.98
Pfizer Inc.1.9
Roche Holding Ltd1.84
Merck & Co. Inc.1.78
Boehringer-Ingelheim GmbH1.73
Bristol-Myers Squibb Co.1.56
Gilead Sciences Inc.1.43
Eli Lilly & Co.0.88
Download Settings Share
Download started
Please be patient - this may take a moment
This statistic depicts a pharmaceutical company ranking based on R&D for developing countries in 2018, according to the Access to Medicine Index 2018. In that year, the leading company concerning research and development for these markets was GlaxoSmithKline with an indicator score of four points. The Access to Medicine Index is an independent initiative that ranks the world’s 20 largest companies according to their efforts to make their products more available, affordable and accessible in developing countries, highlighting policy and practice that either facilitate or hinder access to medicine.
Show more
Statista Accounts: Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$49 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom
Related Studies: Available to Download in PDF or PPTX Format
Monsanto-Bayer
Monsanto-Bayer

All Information
in one Presentation

Monsanto-Bayer

Everything On "Monsanto-Bayer" in One Document: Edited and Divided into Handy Chapters. Including Detailed References.

Statista is a great source of knowledge, and pretty helpful to manage the daily work.
Christof Baron

Christof Baron
CEO, MindShare Germany

Statistics on "Monsanto-Bayer"
  • Overview
  • Financial Data
  • Agricultural Products
  • Pharmaceuticals
The most important statistics
  • Monsanto
Discover Statista
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Learn more about how Statista can support your business.
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.